Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study

Kucukoglu, Mehmet; HANTA, İSMAİL; AKDENİZ, BAHRİ; Gullulu, Sumeyye; Atahan, Ersan; SAYIN, TAMER; Okumus, Gulfer; ÖNEN, ZEYNEP; Yokusoglu, Mehmet; Baygul, Arzu

doi:10.5152/anatoljcardiol.2021.03009

Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study

Kucukoglu M. S., HANTA İ., AKDENİZ B., Gullulu S., Atahan E., SAYIN T., ...More

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.25, no.10, pp.721-732, 2021 (SCI-Expanded, Scopus, TRDizin)

Publication Type: Article / Article
Volume: 25 Issue: 10
Publication Date: 2021
Doi Number: 10.5152/anatoljcardiol.2021.03009
Journal Name: ANATOLIAN JOURNAL OF CARDIOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
Page Numbers: pp.721-732
Keywords: pulmonary arterial hypertension, iloprost, treatment outcome, safety, survival
Dokuz Eylül University Affiliated: Yes

Abstract

Objective: To evaluate clinical efficacy, safety and tolerability of long-term inhaled iloprost treatment in the daily practice for the management of pulmonary arterial hypertension (PAH).